Follow-on Biologics Savings Lower In Administration’s Budget Proposal
This article was originally published in The Pink Sheet Daily
Executive Summary
FOB pathway would create only $6.35 billion in savings, according to the budget, down from the $9.24 billion projected in February.
You may also be interested in...
Follow-On Biologics Legislation Could Come Down to Horse-Trading
Length of brand exclusivity may depend on concession more than reasoned argument, Genzyme’s Holcombe predicts.
Follow-On Biologics Legislation Could Come Down to Horse-Trading
Length of brand exclusivity may depend on concession more than reasoned argument, Genzyme’s Holcombe predicts.
Public Policy – Not The Economy – Must Be Biotech Sector’s Focus, BIO CEO Says
The capital crisis will pass, Greenwood says, but the need to engage on public policy will remain paramount. A sign of a mature industry?